The National Health Insurance Bureau recently issued a circular calling on the provincial health insurance departments to adapt to the changes in the prevention and control situation, and temporarily incorporate COVID-19 antigen detection reagents and corresponding testing items into the basic medical insurance medical service directory. As a supplementary means of nucleic acid detection, antigen detection can be used for screening of specific populations. It supports home operation, and the results are "immediately visible", which can effectively improve the ability of "early detection". Not long ago, the comprehensive group of the joint prevention and control mechanism of the State Council stressed the promotion of the monitoring mode of "antigen screening and nucleic acid diagnosis". The purpose is to strengthen detection, improve the sensitivity of monitoring and early warning, screen infected persons as soon as possible, control the source of infection, and cut off the transmission chain of the epidemic. Epidemic prevention and control is a race against the virus. The earlier the case is found and the less it spreads, we can achieve the maximum prevention and control effect at the least cost and minimize the impact of the epidemic on economic and social development. At present, the centralized purchase price of relevant antigen detection products is 7.9 yuan / person. Further incorporating them into the temporary medical insurance can fully drive the relevant population to "test as much as possible" and facilitate rapid screening and diversion management. This measure not only reflects the strict, practical, scientific and accurate prevention and control concept, but also strongly demonstrates our firm determination and solid support to overcome the epidemic. (Xinhua News Agency)